Results 141 to 150 of about 26,165 (195)

Correction. [PDF]

Redox Rep
europepmc   +1 more source

Artemisinin and its derivatives: all-rounders that may prevent the progression from lung injury to lung cancer. [PDF]

Front Pharmacol
Xie X, Chen Q, Guo C, Zeng J, He Q.
europepmc   +1 more source

A Cox Proportional Hazards Model Approach to Identifying Malaria Risk Factors in Children in South Sudan. [PDF]

Cureus
Jumi LGL, Mohmmed AOA.
europepmc   +1 more source

Single-step versus conventional injectable artesunate for severe malaria in children: an open label, non-inferiority randomized clinical trial, Democratic Republic of the Congo and United Republic of Tanzania. [PDF]

Bull World Health Organ
Gesase S, Onyamboko M, Fanello C, Abdul O, Kayembe DK, Bakomba SB, Minja DT, Nzambiwishe BK, Ekombolo PE, Malabeja A, Mbwana JR, Deen J, Mtove G, Adhikari B, Mapondela M, Taya C, Mutinda B, Waithira N, Lusingu JP, von Seidlein L, Mukaka M, Dondorp AM, Peto TJ.   +22 more
europepmc   +1 more source

Purpura Fulminans With Digital Gangrene in Severe Plasmodium falciparum Malaria: A Case Presentation. [PDF]

Cureus
Palmares I, Morgado C, Dá Mesquita Faustino F, Silva J, Freitas P.   +4 more
europepmc   +1 more source

Spatio-temporal trends of artemisinin-based combination therapy efficacy from 2010 to 2024 in sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

BMC Infect Dis
Bohissou FET, Nassa GJW, Sondo P, Rouamba T, Inoue J, Kaboré B, Asua V, Held J, Tinto H.   +8 more
europepmc   +1 more source

Therapeutic efficacy of dihydroartemisinin-piperaquine and artesunate-pyronaridine combinations in the treatment of uncomplicated <i>Plasmodium falciparum</i> malaria in Ghana, 2023. [PDF]

Front Public Health
Abuaku B, Boateng P, Peprah NY, Asamoah A, Duah-Quashie NO, Matrevi SA, Amoako EO, Quashie N, Owusu-Antwi F, Koram KA, Malm KL.   +10 more
europepmc   +1 more source

The usual suspect-malaria? Diagnostic challenges in post-artesunate delayed haemolysis: a clinical laboratory perspective through a case report. [PDF]

Malar J
Molnar E, Cabral PM, Portal F, Guimarães AR, Santos L, Guimarães JT.   +5 more
europepmc   +1 more source

Accessibility to antimalarials in Spanish hospitals: analysis of a national survey. [PDF]

Malar J
Bretones-Pedrinaci JI, Castro-Vida MA, Urda-Romacho J, Lozano-Serrano AB, Salas-Coronas J.   +4 more
europepmc   +1 more source

Development of a clinical risk scoring system for artesunate treatment failure prediction in malaria patients. [PDF]

Int J Parasitol Drugs Drug Resist
Kim D, Lee DH, Song Y, Kim JS, Gwak HS.
europepmc   +1 more source